Advertisement
Screener

AN2 Therapeutics, Inc. (ANTX) Auditor

AN2 Therapeutics, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-17: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location San Jose, California.
  • 2025-03-25: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location San Jose, California.
  • 2024-03-29: Fiscal year end 2023-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location San Jose, California.
  • 2023-03-29: Fiscal year end 2022-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location San Jose, California.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-172025-12-31PricewaterhouseCoopers LLP238San Jose, CaliforniaNo
2025-03-252024-12-31PricewaterhouseCoopers LLP238San Jose, CaliforniaNo
2024-03-292023-12-31PricewaterhouseCoopers LLP238San Jose, CaliforniaNo
2023-03-292022-12-31PricewaterhouseCoopers LLP238San Jose, CaliforniaNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
PepGen Inc. (PEPG)United States$0.186B-1.73
ALX ONCOLOGY HOLDINGS INC (ALXO)United States$0.187B-3.52
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
Fortress Biotech, Inc. (FBIO)United States$0.188B0.91
Zentalis Pharmaceuticals, Inc. (ZNTL)United States$0.196B-2.48
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
Nkarta, Inc. (NKTX)United States$0.205B-1.73
ADC Therapeutics SA (ADCT)$0.163B-1.39